The tariff classification of Bupropion Hydrochloride Extended-Release Tablets in dosage form, from India
Issued December 3, 2021 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9235
Headings: 3004
Product description
Bupropion Hydrochloride, imported in 150 mg and 300 mg extended-release tablets, is a norepinephrine-dopamine reuptake inhibitor. It is indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD).
CBP rationale
The applicable subheading for the Bupropion Hydrochloride Extended Release Tablets in dosage form will be 3004.90.9235, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments… consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents.
Full text
N322628 December 3, 2021 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9235 Ms. Paulina Radaczynska BluePoint Laboratories 8 Eastgate Avenue Little Island, Cork, T45 NF24 Ireland RE: The tariff classification of Bupropion Hydrochloride Extended-Release Tablets in dosage form, from India Dear Ms. Radaczynska: In your letter dated November 4, 2021, you requested a tariff classification ruling. Bupropion Hydrochloride, imported in 150 mg and 300 mg extended-release tablets, is a norepinephrine-dopamine reuptake inhibitor. It is indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD). The applicable subheading for the Bupropion Hydrochloride Extended Release Tablets in dosage form will be 3004.90.9235, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments… consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification and country of origin of Dr. Reddy’s Nortriptyline Hydrochloride Capsules
The tariff classification of Olanzapine Tablets in dosage form, from India
The tariff classification of Olanzapine Injection in dosage form, from India
The tariff classification of Escitalopram Oxalate Tablets in dosage form, from India
The tariff classification of Prochlorperazine Maleate Tablets in dosage form, from India
The tariff classification of Duloxetine Hydrochloride Delayed-Release Capsules in dosage form, from India
The tariff classification of Quetiapine Fumarate Tablets in dosage form, from India
The tariff classification of Haloperidol Decanoate Injection in dosage form, from India
The tariff classification of Plerixafor Injection and Chlorpromazine Hydrochloride Injection in dosage form, from India and France, respectively
The tariff classification of Lurasidone Hydrochloride Tablets and Teriflunomide Tablets in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →